Lantheus Holdings, Inc. Long-term Debt and Lease Obligation, Including Current Maturities
Lantheus Holdings, Inc. (LNTH) had Long-term Debt and Lease Obligation, Including Current Maturities of $571.05 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Liabilities › Debt
us-gaap:LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities · last filed 2026-08-06
- 2026-06-30: Long-term Debt and Lease Obligation, Including Current Maturities $571.05M.
- 2026-03-31: Long-term Debt and Lease Obligation, Including Current Maturities $570.41M.
- 2025-12-31: Long-term Debt and Lease Obligation, Including Current Maturities $569.42M.
- 2025-09-30: Long-term Debt and Lease Obligation, Including Current Maturities $568.81M.
| Period end | Long-term Debt and Lease Obligation, Including Current Maturities |
|---|---|
| 2026-06-30 | $571.05M 10-Q · filed 2026-08-06 |
| 2026-03-31 | $570.41M 10-Q · filed 2026-05-07 |
| 2025-12-31 | $569.42M 10-Q · filed 2026-08-06 |
| 2025-09-30 | $568.81M 10-Q · filed 2025-11-06 |
| 2025-06-30 | $567.64M 10-Q · filed 2025-08-06 |
| 2025-03-31 | $566.85M 10-Q · filed 2025-05-07 |
| 2024-12-31 | $566.25M 10-K · filed 2026-02-26 |
| 2024-09-30 | $565.33M 10-Q · filed 2024-11-06 |
| 2024-06-30 | $564.06M 10-Q · filed 2024-07-31 |
| 2024-03-31 | $563.20M 10-Q · filed 2024-05-02 |
| 2023-12-31 | $562.49M 10-K · filed 2025-02-26 |
| 2023-09-30 | $561.28M 10-Q · filed 2023-11-02 |
| 2023-06-30 | $559.62M 10-Q · filed 2023-08-03 |
| 2023-03-31 | $558.96M 10-Q · filed 2023-05-04 |
| 2022-09-30 | $167.43M 10-Q · filed 2022-11-03 |
| 2022-06-30 | $169.73M 10-Q · filed 2022-08-04 |
| 2022-03-31 | $172.25M 10-Q · filed 2022-04-29 |
| 2021-09-30 | $177.10M 10-Q · filed 2021-11-04 |
| 2021-06-30 | $179.62M 10-Q · filed 2021-07-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEOGEN CORP (NEOG) | United States | $2.979B | -247.49 |
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B |